Earnings Release • Apr 29, 2020
Earnings Release
Open in ViewerOpens in native device viewer

Ieper, Belgium – April 29th, 2020, 07.00 hrs CET
| CONFORM IFRS | Q1 2020 | Q1 2019 | YOY growth | Q4 2019 | SEQ growth |
|---|---|---|---|---|---|
| in k EUR | (%) | (%) | |||
| Sales | 138,162 | 116,511 | 19% | 127,052 | 9% |
| Gross result | 56,033 | 46,755 | 20% | 50,424 | 11% |
| Gross Margin | 40.6% | 40.1% | 39.7% | ||
| EBIT | 23,980 | 15,739 | 52% | 18,280 | 31% |
| EBIT in % | 17.4% | 13.5% | 14.4% | ||
| EBITDA | 36,112 | 27,932 | 29% | 30,773 | 17% |
| EBITDA in % | 26.1% | 24.0% | 24.2% | ||
| Net result | 20,706 | 13,946 | 48% | 15,371 | 35% |
| Net result per share (EPS) | 0.51 | 0.35 | 0.38 | ||
| CAPEX | 6,783 | 6,987 | 6,081 |
Sales for the first quarter of 2020 were 138.2 million EUR, an increase of 19% compared to the same quarter of the previous year and an increase of 9% compared to the previous quarter.
The EUR/USD exchange rate evolution had a positive impact on sales of 1% compared to the same quarter of last year and no impact compared to the previous quarter.
The gross result was 56.0 million EUR or 40.6% of sales, an increase of 20% compared to the same quarter of last year and an increase of 11% compared to the previous quarter.
R&D expenses were 14.9% of sales, G&A was at 5.7% of sales and Selling was at 2.7% of sales. The operating result was 24.0 million EUR or 17.4% of sales, an increase of 52% compared to the same quarter of last year and an increase of 31% compared to the previous quarter.
The net result was 20.7 million EUR or 0.51 EUR per share, an increase of 48% compared to 13.9 million EUR or 0.35 EUR per share in the first quarter of 2019 and an increase of 35% compared to the previous quarter.
Melexis reiterates its announcement of April 1st to withdraw its full year 2020 outlook, as the economic impact resulting from the COVID-19 pandemic cannot be quantified at this moment.
"Melexis had a solid start of the year with a 19% year-over-year and a 9% sequential sales growth, which is at the high end of the sales guidance provided at the beginning of the year. Leaving aside the negative impact of COVID-19 at the end of March, sales were heading for more than 140 million EUR.
Melexis continues to serve customers in the best possible way, despite ongoing supply chain disruptions, mainly in chip assembly (packaging). On the demand side, many customers - mainly in Europe and the US have shut down due to COVID-19 lockdown measures, while mostly Asian customers have restarted operations. The combined impact of disruptions, both on the supply and the demand side, will have a significant negative impact on sales in the second quarter. A positive element, which we expect will soften the impact, is that inventory levels of Melexis' products at customer level are estimated to be low.

In the first quarter, the outperforming product lines were temperature sensors, pressure sensors, magnetic position sensors and embedded motor drivers.
As announced earlier, stronger demand in temperature sensors is linked to the fact that our products are critical components to much of the equipment to overcome the COVID-19 pandemic, ranging from diagnostics, over fever measurement and respiratory devices.
In the automotive industry, the China 6 norm benefits our pressure sensors in multiple ways, for example in the area of gasoline particulate filters.
New magnetic position sensor content growth comes from the chassis, transmission, and braking areas thanks to x-by-wire operation, additional controls and higher functional safety and reliability. Autonomous driving and electrified powertrains, for example, create new challenges that our 3rd generation Triaxis® sensors are able to meet with their high functional safety level and stray field robust mode.
We observe an increasing trend, both for new energy and for conventional fuel cars, towards small cooling pumps or sensored cooling valves for better thermal management, which is being served with our embedded motor drivers. Melexis has also been benefiting from more sales for air grille shutters which reduce fuel or battery energy consumption.
Sales to automotive customers represented 91% of total sales in the first quarter of 2020. The portion of standard product (ASSPs) sales represented 65% of total sales in the first quarter of 2020."
The company's results will be discussed in a conference call on Wednesday, April 29th, 2020 at 10:30 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information.
After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call.
For more information: Investor Relations Phone: +32 13 67 07 79 Email: [email protected]
Combining a passion for technology with truly inspired engineering, Melexis designs, develops and delivers innovative micro-electronic solutions that enable designers to turn ideas into applications that support the best imaginable future. The company's advanced mixed-signal semiconductor sensor and actuator components address the challenges of integrating sensing, driving and communication into next-generation products and systems that improve safety, raise efficiency, support sustainability and enhance comfort. Melexis is headquartered in Belgium and employs over 1500 people in 19 locations worldwide. The company is publicly traded on Euronext Brussels (MELE). For more information, visit www.melexis.com

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forwardlooking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

| CONFORM IFRS | Quarter ended 31/03/2020 |
Quarter ended 31/03/2019 |
Year ended 31/12/2019 |
|---|---|---|---|
| in k EUR | audited | ||
| Sales | 138,162 | 116,511 | 486,862 |
| Cost of sales | -82,129 | -69,756 | -290,628 |
| Gross result | 56,033 | 46,755 | 196,234 |
| R&D | -20,519 | -19,763 | -79,558 |
| G&A | -7,815 | -7,599 | -30,600 |
| Selling | -3,719 | -3,653 | -15,450 |
| Other operating result | |||
| Operating result (EBIT) | 23,980 | 15,739 | 70,626 |
| Financial result | -449 | -333 | -1,378 |
| Result before taxes | 23,530 | 15,406 | 69,248 |
| Income taxes | -2,824 | -1,460 | -8,993 |
| Net result | 20,706 | 13,946 | 60,255 |
| Net result per share in EUR | 0.51 | 0.35 | 1.49 |
| CONFORM IFRS | Quarter ended 31/03/2020 |
Quarter ended 31/03/2019 |
Year ended 31/12/2019 |
|---|---|---|---|
| in k EUR | audited | ||
| Current Assets : | |||
| Cash and cash equivalents | 51,051 | 39,554 | 38,772 |
| Current investments | 2 | 0 | 78 |
| A/R Trade | 69,149 | 65,678 | 58,310 |
| A/R from related parties | 61 | 272 | 136 |
| Advance related parties | |||
| Assets for current tax | 1,848 | 1,243 | 1,745 |
| Assets held for sale | |||
| Other current assets | 12,833 | 11,701 | 9,781 |
| Inventories | 129,887 | 124,941 | 128,505 |
| Total current assets | 264,832 | 243,387 | 237,328 |
| Non-current assets : | |||
| Costs of incorporation | |||
| Property, plant and equipment | 140,711 | 154,699 | 143,608 |
| Leased assets | 4,489 | 5,177 | 4,813 |
| Financial assets | 0 | 0 | 0 |
| Intangible fixed assets | 4,765 | 4,926 | 5,209 |
| A/R directors | |||
| Other non-current assets | 3 | 8 | 3 |
| Deferred tax assets | 28,057 | 24,477 | 27,649 |
| Total non current assets | 178,025 | 189,288 | 181,282 |
| Total assets | 442,857 | 432,675 | 418,610 |

| CONFORM IFRS | Quarter ended 31/03/2020 |
Quarter ended 31/03/2019 |
Year ended 31/12/2019 |
|---|---|---|---|
| in k EUR | audited | ||
| Liabilities and shareholders Equity | |||
| Current liabilities : | |||
| Bank loans and overdrafts | |||
| Derivative financial instruments | 0 | 25 | 0 |
| Current portion of LT debt | 0 | 1,000 | 0 |
| Lease liabilities | 1,405 | 1,013 | 1,825 |
| A/P trade | 15,160 | 16,737 | 16,139 |
| Affiliated companies | 16,588 | 13,473 | 15,733 |
| Accrued taxes | 2,603 | 2,264 | 3,251 |
| Accrued expenses and payroll | 15,366 | 13,693 | 10,643 |
| Other current liabilities | 4,710 | 3,078 | 4,305 |
| Deferred income | 2,012 | 2,978 | 2,280 |
| Total current liabilities | 57,845 | 54,262 | 54,176 |
| Non current liabilities : | |||
| LT debt less current portion | 62,000 | 34,000 | 62,000 |
| Lease liabilities | 3,127 | 3,791 | 3,027 |
| Deferred tax liabilities | 327 | 280 | 337 |
| Other non-current liabilities | 0 | 0 | 0 |
| Total non current liabilities | 65,454 | 38,070 | 65,364 |
| Shareholders' equity : | |||
| Shareholders' capital Share premium |
565 | 565 | 565 |
| Treasury shares | -3,818 | -3,818 | -3,818 |
| Revaluation reserve Hedge | 0 | 0 | 0 |
| Revaluation reserve Fair value | 0 | 0 | 0 |
| Legal reserve | 57 | 57 | 57 |
| Retained earnings | 306,856 | 334,719 | 246,601 |
| Current period's profit | 20,706 | 13,946 | 60,255 |
| Cumulative translation adjustment | -4,808 | -5,137 | -4,590 |
| Equity attributable to company owners | 319,557 | 340,332 | 299,070 |
| Non controlling interests | 0 | 10 | 0 |
| Total shareholders equity | 319,558 | 340,343 | 299,070 |
| Total liabilities, shareholders' equity | 442,857 | 432,675 | 418,610 |
| and minority interests |

| CONFORM IFRS | Quarter ended | Quarter ended | Year ended |
|---|---|---|---|
| 31/03/2020 | 31/03/2019 | 31/12/2019 | |
| (in k EUR) | audited | ||
| Cash flow from operating activities | |||
| Net income Adjustments for : |
20,706 0 |
13,946 0 |
60,255 |
| Operating activities | 14,887 | 14,418 | 59,459 |
| Deferred taxes | -408 | 517 | -2,655 |
| Capital grants | 193 | 173 | 1,099 |
| Depreciation and amortisation | 11,654 | 11,780 | 46,760 |
| Depreciation leased assets | 479 | 413 | 1,845 |
| Accrued income tax | 2,590 | 356 | 10,374 |
| Unrealized exchange results | -3 | -36 | -604 |
| Financial result | 382 | 1,217 | 2,640 |
| Operating profit before working capital changes | 35,592 | 28,364 | 119,714 |
| A/R, Trade | -10,866 | 9,555 | 16,938 |
| A/R, affiliates | 74 | -111 | 25 |
| Other current assets | -3,325 | -3,214 | -2,687 |
| Other non current assets | 0 | -4 | 1 |
| Inventories | -2,913 | -6,222 | -14,303 |
| A/P | -955 | -4,138 | -4,678 |
| A/P affiliates | 856 | -495 | 1,765 |
| Accrued expenses | 4,723 | 3,192 | 141 |
| Other current liabilities | 302 | 121 | 1,537 |
| Other non current liabilities | -278 | -56 | -721 |
| Interest paid Income tax paid |
-124 -3,238 |
-120 -13,776 |
-523 -22,808 |
| Cash flow from operating activities | 19,850 | 13,097 | 94,400 |
| 0 | 0 | ||
| 0 | 0 | ||
| Cash flow from investing activities | 0 | 0 | |
| Acquisition of subsidiary, net of cash acquired | 0 | 0 | |
| Financial fixed assets | 0 | 0 | |
| Purchase of PPE and intangible assets (netted) | -6,783 | -6,987 | -26,632 |
| Interest received | 31 | 0 | 90 |
| Investments/proceeds/ from current investments | 76 | 101 | 22 |
| Investments/proceeds/ from non current investments | 0 | 0 | |
| (incl. financial instruments) | 0 | 0 | |
| Cash provided from investing activities | -6,676 | -6,886 | -26,519 |
| 0 | 0 | ||
| Cash flows from financing activities Payment to acquire own shares |
0 0 |
0 0 |
|
| Proceeds/Repayment of long-and short-term debt | -21 | -82 | 26,927 |
| Proceeds/Repayment of bank loans and overdrafts | 0 | 0 | |
| Repayment leasings | -475 | -786 | -1,805 |
| Proceeds from (repayment of) related party financing | 0 | 0 | |
| Impact of exchange results on financing items | -349 | -357 | -661 |
| Dividend payment | 0 | 0 | -88,118 |
| Capital Decrease | 0 | 0 | |
| Non controlling interests | 0 | 0 | -10 |
| Cash provided from financing activities | -845 | -1,225 | -63,668 |
| 0 | 0 | ||
| CTA | -49 | 46 | 37 |
| Increase/decrease in cash and cash equivalents | 12,279 | 5,032 | 4,250 |
| Cash at beginning of the period | 38,772 | 34,522 | 34,522 |
| Cash at the end of the period | 51,051 | 39,554 | 38,772 |

| Q1 2020 | Q1 2019 | FY 2019 | |
|---|---|---|---|
| APAC Asia Pacific |
51% | 44% | 47% |
| EMEA Europe - Middle-East - Africa |
36% | 42% | 39% |
| NALA North America - Latin America |
13% | 14% | 14% |
| TOTAL | 100% | 100% | 100% |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.